Clinical and genetic analysis of two Chinese infants with Mabry syndrome



      Hyperphosphatasia mental retardation syndrome (Mabry syndrome) is an autosomal recessive disorder. We aim to analyze two Chinese patients diagnosed as Mabry syndrome.


      The clinical manifestations, diagnosis and treatment were observed in two patients. Genetic analysis including PIGV and PIGO was examined.


      Two patients were diagnosed as Mabry syndrome clinically and genetically. Developmental delay, hyperphosphatasia and seizures were presented in both of them. Typical facial dysmorphism and hypoplastic terminal phalanges were only found in one. Some novel presentations including congenital laryngeal cartilage softening, inguinal hernia, broken palmprint, optic atrophy and skeleton dysplasia such as carpal age delay and metaphysis anomalies were observed in two patients. Molecular genetic analysis revealed compound heterozygous mutations of PIGV or PIGO in our patients, including c.615C > G (p.Asn205Lys) and c.854A > G (p.Tyr285Cys) of PIGV in patient 1, and c.458T > C (p.Phe153Ser) and c.1355_1356del (p.Ala452Glyfs*52) of PIGO in patient 2. Additionally, a heterozygous c.2926G > A (Asp976Asn) of PCDH19 was identified in patient with PIGV mutations, the causative gene of Epilepsy and mental retardation limited to females (EFMR).


      To our best knowledge, this is the first time to report Chinese patients diagnosed as Mabry syndrome. For the PCDH19 mutation in our patient carrying PIGV mutations, due to lacking characteristics of EFMR and the ambiguity results in pathogenicity analysis, we were not sure how much pathogenic role PCDH19 mutation shared with PIGV mutations in this disease. The novel mutations of PIGV and PIGO, and novel clinical manifestations reported here might expand the genotype and phenotype spectrum of Mabry syndrome.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mabry C.C.
        • Bautista A.
        • Kirk R.F.H.
        • Dubilier L.D.
        • Braunstein H.
        • Koepke J.A.
        Familial hyperphosphatase with mental retardation, seizures, and neurologic deficits.
        J Pediatr. 1970; 77: 74-85
        • Thompson M.D.
        • Nezarati M.M.
        • Gillessen-Kaesbach G.
        • Meinecke P.
        • Mendoza-Londono R.
        • Mornet E.
        • et al.
        Hyperphosphatasia with seizures, neurologic deficit, and characteristic facial features: five new patients with Mabry syndrome.
        Am J Med Genet Part A. 2010; 152A: 1661-1669
        • Thompson M.D.
        • Roscioli T.
        • Marcelis C.
        • Nezarati M.M.
        • Stolte-Dijkstra I.
        • Sharom F.J.
        • et al.
        Phenotypic variability in hyperphosphatasia with seizures and neurologic deficit (Mabry syndrome).
        Am J Med Genet Part A. 2012; 158A: 553-558
        • Horn D.
        • Schottmann G.
        • Meinecke P.
        Hyperphosphatasia with mental retardation, brachytelephalangy, and a distinct facial gestalt: delineation of a recognizable syndrome.
        Eur J Med Genet. 2010; 53: 85-88
        • Horn D.
        • Krawitz P.
        • Mannhardt A.
        • Korenke G.C.
        • Meinecke P.
        Hyperphosphatasia-mental retardation syndrome due to PIGV mutations: expanded clinical spectrum.
        Med Genet Part A. 2011; 155A: 1917-1922
        • Horn D.
        • Wieczorek D.
        • Metcalfe K.
        • Barić I.
        • Paležac L.
        • Cuk M.
        • et al.
        Delineation of PIGV mutation spectrum and associated phenotypes in hyperphosphatasia with mental retardation syndrome.
        Eur J Hum Genet. 2014; 22: 762-767
        • Krawitz P.M.
        • Schweiger M.R.
        • Rödelsperger C.
        • Marcelis C.
        • Kölsch U.
        • Meisel C.
        • et al.
        Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome.
        Nat Genet. 2010; 42: 827-829
        • Krawitz P.M.
        • Murakami Y.
        • Hecht J.
        • Krüger U.
        • Holder S.E.
        • Mortier G.R.
        • et al.
        Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation.
        Am J Hum Genet. 2012; 91: 146-151
        • Krawitz P.M.
        • Murakami Y.
        • Rieß A.
        • Hietala M.
        • Krüger U.
        • Zhu N.
        • et al.
        PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome.
        Am J Hum Genet. 2013; 92: 584-589
        • Howard M.F.
        • Murakami Y.
        • Pagnamenta A.T.
        • Daumer-Haas C.
        • Fischer B.
        • Hecht J.
        • et al.
        Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation.
        Am J Hum Genet. 2014; 94: 278-287
        • Fujiwara I.
        • Murakami Y.
        • Niihori T.
        • Kanno J.
        • Hakoda A.
        • Sakamoto O.
        • et al.
        Mutations in PIGL in a patient with Mabry syndrome.
        Am J Med Genet A. 2015; 167A: 777-785
        • Chiyonobu T.
        • Inoue N.
        • Morimoto M.
        • Kinoshita T.
        • Murakami Y.
        Glycosylphosphatidylinositol (GPI) anchor deficiency caused by mutations in PIGW is associated with West syndrome and hyperphosphatasia with mental retardation syndrome.
        J Med Genet. 2014; 51: 203-207
        • Kong W.
        • Zhang Y.
        • Gao Y.
        • Liu X.
        • Gao K.
        • Xie H.
        • et al.
        SCN8A mutations in Chinese children with early onset epilepsy and intellectual disability.
        Epilepsia. 2015; 56: 431-438
        • Adzhubei I.A.
        • Schmidt S.
        • Peshkin L.
        • Ramensky V.E.
        • Gerasimova A.
        • Bork P.
        • et al.
        A method and server for predicting damaging missense mutations.
        Nat Methods. 2010; 7: 248-249
        • Nakamura K.
        • Osaka H.
        • Murakami Y.
        • Anzai R.
        • Nishiyama K.
        • Kodera H.
        • et al.
        PIGO mutations in intractable epilepsy and severe developmental delay with mild elevation of alkaline phosphatase levels.
        Epilepsia. 2014; 55 (e13–7)
        • Kuki I.
        • Takahashi Y.
        • Okazaki S.
        • Kawawaki H.
        • Ehara E.
        • Inoue N.
        • et al.
        Vitamin B6-responsive epilepsy due to inherited GPI deficiency.
        Neurology. 2013; 81: 1467-1469
        • Dibbens L.M.
        • Tarpey P.S.
        • Hynes K.
        • Bayly M.A.
        • Scheffer I.E.
        • Smith R.
        • et al.
        X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment.
        Nat Genet. 2008; 40: 776-781
        • Depienne C.
        • Gourfinkel-An I.
        • Baulac S.
        • LeGuern E.
        Genes in infantile epileptic encephalopathies.
        in: Noebels J.L. Avoli M. Rogawski M.A. Olsen R.W. Delgado-Escueta A.V. Jasper’s basic mechanisms of the epilepsies [internet]. 4th ed. National Center for Biotechnology Information (US), Bethesda (MD)2012
        • Fabisiak K.
        • Erickson R.P.
        A familial form of convulsive disorder with or without mental retardation limited to females: extension of a pedigree limits possible genetic mechanisms.
        Clin Genet. 1990; 38: 353-358
        • Juberg R.C.
        • Hellman C.D.
        A new familial form of convulsive disorder and mental retardation limited to females.
        J Pediatr. 1971; 79: 726-732
        • Ryan S.G.
        • Chance P.F.
        • Zou C.H.
        • Spinner N.B.
        • Golden J.A.
        • Smietana S.
        Epilepsy and mental retardation limited to females: an X-linked dominant disorder with male sparing.
        Nat Genet. 1997; 17: 92-95
        • Depienne C.
        • Bouteiller D.
        • Keren B.
        • Cheuret E.
        • Poirier K.
        • Trouillard O.
        • et al.
        Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females.
        PLoS Genet. 2009; 5: e1000381
        • Depienne C.
        • Trouillard O.
        • Bouteiller D.
        • Gourfinkel-An I.
        • Poirier K.
        • Rivier F.
        • et al.
        Mutations and deletions in PCDH19 account for various familial or isolated epilepsies in females.
        Hum Mutat. 2011; 32: E1959-E1975
        • Marini C.
        • Mei D.
        • Parmeggiani L.
        • Norci V.
        • Calado E.
        • Ferrari A.
        • et al.
        Protocadherin 19 mutations in girls with infantile-onset epilepsy.
        Neurology. 2010; 75: 646-653
        • Kang J.Y.
        • Hong Y.
        • Ashida H.
        • Shishioh N.
        • Murakami Y.
        • Morita Y.S.
        • et al.
        PIG-V involved in transferring the second mannose in glycosylphosphatidylinositol.
        J Biol Chem. 2005; 280: 9489-9497
        • Hong Y.
        • Maeda Y.
        • Watanabe R.
        • Inoue N.
        • Ohishi K.
        • Kinoshita T.
        Requirement of PIG-F and PIG-O for transferring phosphoethanolamine to the third mannose in glycosylphosphatidylinositol.
        J Biol Chem. 2000; 275: 20911-20919
        • Murakami Y.
        • Kanzawa N.
        • Saito K.
        • Krawitz P.M.
        • Mundlos S.
        • Robinson P.N.
        • et al.
        Mechanism for release of alkaline phosphatase caused by glycosylphosphatidylinositol deficiency in patients with hyperphosphatasia mental retardation syndrome.
        J Biol Chem. 2012; 287: 6318-6325
        • Maeda Y.
        • Tashima Y.
        • Houjou T.
        • Fujita M.
        • Yoko-o T.
        • Jigami Y.
        • et al.
        Fatty acid remodeling of GPI-anchored proteins is required for their raft association.
        Mol Biol Cell. 2007; 18: 1497-1506
        • Thompson M.D.
        • Killoran A.
        • Percy M.E.
        • Nezarati M.
        • Cole D.E.
        • Hwang P.A.
        Hyperphosphatasia with neurologic deficit: a pyridoxine-responsive seizure disorder?.
        Pediatr Neurol. 2006; 34: 303-307